SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-013119
Filing Date
2022-04-01
Accepted
2022-04-01 16:30:50
Documents
2
Period of Report
2022-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4115
2 EX-24 DOCUMENT attachment1.htm EX-24 5575
  Complete submission text file 0000899243-22-013119.txt   11232
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BLDG 34 BOSTON MA 02129
Business Address
Boyle Kevin S. Sr. (Reporting) CIK: 0001880600 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 22798737